March 2 (Reuters) - Oncolytics Biotech Inc ONC.TO
* Oncolytics Biotech Inc. announces Canadian cancer trials group to present final randomized data from phase 2 metastatic breast cancer study at AACR 2017 annual meeting Source text for Eikon: ID:nCNWh3V10a Further company coverage: ONC.TO